Tag: FDA gene therapy approval process for rare diseases
Complete Guide to FDA Rare Disease Gene Therapy Approval Process (2024): Timelines, Fast Track, Breakthrough Designation & Orphan Drug Act Benefits
Per October 2024 FDA guidance, 2023 National Organization for Rare Disorders (NORD) data, and 2024 Tufts Center for the Study of Drug Development reports, 95% of U.S. rare diseases lack approved treatments, but new 2024 pathways cut rare disease gene therapy approval timelines by 40-60%. This 2024 buying guide breaks down Premium vs Counterfeit Regulatory